Wave Life Sciences Ltd. (WVE)
NASDAQ: WVE · Real-Time Price · USD
13.09
-1.36 (-9.41%)
At close: Dec 18, 2024, 4:00 PM
13.00
-0.09 (-0.69%)
Pre-market: Dec 19, 2024, 4:36 AM EST
Wave Life Sciences Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Wave Life Sciences stock have an average target of 21.6, with a low estimate of 15 and a high estimate of 36. The average target predicts an increase of 65.01% from the current stock price of 13.09.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for WVE stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 4 | 5 | 5 | 5 |
| Buy | 4 | 3 | 4 | 4 | 4 | 4 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 9 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho | Mizuho | Buy Maintains $19 → $22 | Buy | Maintains | $19 → $22 | +68.07% | Nov 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +68.07% | Nov 13, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $17 → $36 | Strong Buy | Maintains | $17 → $36 | +175.02% | Nov 12, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $19 → $22 | Strong Buy | Maintains | $19 → $22 | +68.07% | Nov 4, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +68.07% | Oct 31, 2024 |
Financial Forecast
Revenue This Year
52.71M
from 113.31M
Decreased by -53.48%
Revenue Next Year
78.32M
from 52.71M
Increased by 48.58%
EPS This Year
-1.16
from -0.54
EPS Next Year
-1.07
from -1.16
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 99.5M | 107.1M | 213.2M | |||
| Avg | 52.7M | 78.3M | 108.0M | |||
| Low | 25.8M | 33.9M | 41.2M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -12.1% | 103.2% | 172.2% | |||
| Avg | -53.5% | 48.6% | 37.9% | |||
| Low | -77.2% | -35.7% | -47.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -0.90 | -0.78 | -0.72 | |||
| Avg | -1.16 | -1.07 | -1.00 | |||
| Low | -1.34 | -1.60 | -1.27 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.